Dyne Therapeutics, Inc. (DYN)
15.92
-0.62
(-3.75%)
USD |
NASDAQ |
May 19, 16:00
16.00
+0.08
(+0.50%)
After-Hours: 07:51
Dyne Therapeutics Total Assets (Quarterly) : 1.080B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| BioCryst Pharmaceuticals, Inc. | 465.05M |
| Biogen, Inc. | 29.48B |
| Insmed, Inc. | 2.076B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 214.90M |
| Shareholders Equity (Quarterly) | 865.06M |
| Debt to Equity Ratio | 0.2022 |
| Current Ratio | 19.92 |
| Net Debt Paydown Yield | -1.01% |